QuantRx Biomedical Corporation
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From QuantRx Biomedical Corporation
Keeping Track: Clarus, Agile and Sunovion Look To Bounce Back From CRLs; FDA To Review Rituximab Biosimilar
The latest drug development news and highlights from our US FDA Performance Tracker.
Will New CEOs Make C-Suite More 'She-Suite'?
Improving gender balance in top pharma is a slow process, but not a gradual one. Management shake-ups often implemented by newly appointed CEOs could help.
EpiPen Familiarity May Prove Tough Hurdle For Generics
With EpiPen injector patent-protected and patients accustomed to its use, finding a substitutable generic device may prove difficult.
Deals Update
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Company Information
- Industry
- Research, Analytical Equipment & Supplies
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
- Urine-based Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
- Other Names / Subsidiaries
-
- NuRx Pharmaceuticals, Inc.
- QX Labs
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
QuantRx Biomedical Corporation
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice